Figure 4. Polypeptide plots from patient no. 291 (no complications) and patient no. 293 (GVHD). Polypeptide plots (polypeptide mass over CE migration time) are shown for 2 patients, no. 291 (A) and no. 294 (B), at an early posttransplantation period. While patient 291 had no complications in the observation period, patient 294 was diagnosed with GVHD on day +14. To visualize the search for biomarkers and to show the differences between these patients, panel C shows a magnified view of the plots obtained at different days after HSCT (0 to +13/+35 as shown by the black arrow) of the polypeptide 1.85 kDa/34 minutes. This polypeptide appears in the samples of patient 293, as early as day +1, showing increasing intensity over the progression of GVHD (arrow, starting at day +15, indicating the clinical diagnosis of GVHD).
Figure 4.

Polypeptide plots from patient no. 291 (no complications) and patient no. 293 (GVHD). Polypeptide plots (polypeptide mass over CE migration time) are shown for 2 patients, no. 291 (A) and no. 294 (B), at an early posttransplantation period. While patient 291 had no complications in the observation period, patient 294 was diagnosed with GVHD on day +14. To visualize the search for biomarkers and to show the differences between these patients, panel C shows a magnified view of the plots obtained at different days after HSCT (0 to +13/+35 as shown by the black arrow) of the polypeptide 1.85 kDa/34 minutes. This polypeptide appears in the samples of patient 293, as early as day +1, showing increasing intensity over the progression of GVHD (arrow, starting at day +15, indicating the clinical diagnosis of GVHD).

or Create an Account

Close Modal
Close Modal